Stavros G. Vizirgianakis - 16 Apr 2025 Form 3 Insider Report for Medinotec Inc. (MDNC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
12 Jun 2025, 12:18:42 UTC
Prior SEC filing
17 Jan 2025
Next SEC filing
19 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stavros G. Vizirgianakis
Filing notes and source

Key filing fact

Stavros G. Vizirgianakis filed Form 3 for Medinotec Inc. (MDNC) on 12 Jun 2025.

Key facts

  • This page summarizes Stavros G. Vizirgianakis's Form 3 filing for Medinotec Inc. (MDNC).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Jun 2025, 12:18.

Change

  • Previous filing in this sequence was filed on 17 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001559834 Primary reporting owner

Vizirgianakis Stavros G.

Relationship
Director, 10%+ Owner
Address
C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE
Signature
/s/ Stavros G. Vizirgianakis
Signature date
12 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDNC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,750,179
Date
16 Apr 2025
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .